基本信息
文件名称：AR-antagonist-13-生命科学试剂-MCE.pdf
文件大小：455.06 KB
总页数：1 页
更新时间：2025-06-12
总字数：约1.83千字
文档摘要
Hotline:400-820-3792
Inhibitors?ScreeningLibraries?Proteins
www.MedChemE
ARantagonist13
Cat.No.:HY-172612
分?式:C??H??N?O
分?量:476.65
作?靶点:AndrogenReceptor
作?通路:VitaminDRelated/NuclearReceptor
储存?式:Pleasestoretheproductundertherecommendedconditionsin
theCertificateofAnalysis.
BIOLOGICALACTIVITY
?物活性ARantagonist13(compound19)是?种雄激素受体(androgenreceptor)拮抗剂，在10μM下抑制率超过
71.5%。ARantagonist13抑制前列腺癌细胞?长。
REFERENCES
[1].JiangH,etal.Synthesis,bioactivity,andmoleculardockingstudies:novelarylpiperazinederivativesaspotentialnew-resistantAR
antagonists.FrontChem.2025Mar28;13:1557275.
McePdfHeight
Caution:Producthasnotbeenfullyvalidatedformedicalapplications.
Forresearchuseonly.
Tel:400-820-3792;021Fax:021E-mail:tech@MedChemE
1/1MasterofBioactiveMolecules—您?边的抑制剂?师